These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946 [TBL] [Abstract][Full Text] [Related]
6. Dynamic sequential MR imaging of focal liver lesions: initial experience in 22 patients at 1.5 T. Schmiedl U; Kölbel G; Hess CF; Klose U; Kurtz B J Comput Assist Tomogr; 1990; 14(4):600-7. PubMed ID: 2164538 [TBL] [Abstract][Full Text] [Related]
7. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951 [TBL] [Abstract][Full Text] [Related]
8. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA]. Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558 [TBL] [Abstract][Full Text] [Related]
9. Hepatic tumors: magnetization transfer MR imaging with gadolinium enhancement. Onaya H; Yoshioka H; Itai Y; Niitsu M; Anno I; Okumura T J Magn Reson Imaging; 1995; 5(3):273-9. PubMed ID: 7633103 [TBL] [Abstract][Full Text] [Related]
10. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. Cheng WZ; Zeng MS; Yan FH; Rao SX; Shen JZ; Chen CZ; Zhang SJ; Shi WB World J Gastroenterol; 2007 Sep; 13(36):4891-6. PubMed ID: 17828821 [TBL] [Abstract][Full Text] [Related]
11. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI]. Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107 [TBL] [Abstract][Full Text] [Related]
12. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329 [TBL] [Abstract][Full Text] [Related]
15. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation. Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073 [TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results]. Hamm B; Römer T; Felix R; Wolf KJ Rofo; 1986 Dec; 145(6):684-91. PubMed ID: 3025957 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic strategy in liver and pancreatic tumors: imaging diagnosis using MRT]. Langkowski JH Rontgenblatter; 1989 Sep; 42(9):400-5. PubMed ID: 2552566 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Fowler KJ; Brown JJ; Narra VR Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400 [TBL] [Abstract][Full Text] [Related]
19. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat. Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496 [TBL] [Abstract][Full Text] [Related]